Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: comment on the article by Rovin et al. uri icon

Overview

publication date

  • October 1, 2012

Research

keywords

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Lupus Nephritis

Identity

Scopus Document Identifier

  • 84869007040

Digital Object Identifier (DOI)

  • 10.1002/art.34617

PubMed ID

  • 22777724

Additional Document Info

volume

  • 64

issue

  • 10